Aveir VR Coverage With Evidence Development Post-Approval Study
Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age18+
SponsorAbbott Medical Devices
About this trial
The purpose of this coverage with evidence development (CED) study is to evaluate complications and long-term health outcomes of the single-chamber Aveir Single-Chamber Leadless Pacemaker device (Aveir VR LP).
Eligibility criteria
Qualifiers
None
Disqualifiers
None
Trial design
Treatments tested in this trial
- Aveir VR Leadless Pacemaker System
- Single-Chamber Transvenous Pacemaker
Treatment groups
8,744 Participants
are divided into 2 treatment groupsSponsors and collaborators
Source ClinicalTrials.gov